These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27447939)

  • 1. Transporters as Drug Targets in Neurological Diseases.
    Qosa H; Mohamed LA; Alqahtani S; Abuasal BS; Hill RA; Kaddoumi A
    Clin Pharmacol Ther; 2016 Nov; 100(5):441-453. PubMed ID: 27447939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CNS transporters in the pharmacotherapy of HIV-1 associated neurological disorders.
    Ashraf T; Robillard K; Chan GN; Bendayan R
    Curr Pharm Des; 2014; 20(10):1543-63. PubMed ID: 23789949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting voltage-gated calcium channels in neurological and psychiatric diseases.
    Zamponi GW
    Nat Rev Drug Discov; 2016 Jan; 15(1):19-34. PubMed ID: 26542451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC transporters as therapeutic targets: emerging opportunities.
    Lin L; Yee SW; Kim RB; Giacomini KM
    Nat Rev Drug Discov; 2015 Aug; 14(8):543-60. PubMed ID: 26111766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters.
    Vaughan RA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):1-7. PubMed ID: 15064332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ephs and ephrins: emerging therapeutic targets in neuropathology.
    Attwood BK; Patel S; Pawlak R
    Int J Biochem Cell Biol; 2012 Apr; 44(4):578-81. PubMed ID: 22265656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLT-1 transporter: an effective pharmacological target for various neurological disorders.
    Soni N; Reddy BV; Kumar P
    Pharmacol Biochem Behav; 2014 Dec; 127():70-81. PubMed ID: 25312503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional expression of drug transporters in glial cells: potential role on drug delivery to the CNS.
    Ashraf T; Kao A; Bendayan R
    Adv Pharmacol; 2014; 71():45-111. PubMed ID: 25307214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotransmitter transporters: why dance with so many partners?
    González MI; Robinson MB
    Curr Opin Pharmacol; 2004 Feb; 4(1):30-5. PubMed ID: 15018836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extracellular signal-regulated kinase 1/2 pathway in neurological diseases: A potential therapeutic target (Review).
    Sun J; Nan G
    Int J Mol Med; 2017 Jun; 39(6):1338-1346. PubMed ID: 28440493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy and lysosomal pathways in nervous system disorders.
    Bingol B
    Mol Cell Neurosci; 2018 Sep; 91():167-208. PubMed ID: 29729319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMPA Receptors as Therapeutic Targets for Neurological Disorders.
    Lee K; Goodman L; Fourie C; Schenk S; Leitch B; Montgomery JM
    Adv Protein Chem Struct Biol; 2016; 103():203-61. PubMed ID: 26920691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug transporters at brain barriers: expression and regulation by neurological disorders.
    Ashraf T; Kis O; Banerjee N; Bendayan R
    Adv Exp Med Biol; 2012; 763():20-69. PubMed ID: 23397618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial Na(+) -dependent ion transporters in pathophysiological conditions.
    Boscia F; Begum G; Pignataro G; Sirabella R; Cuomo O; Casamassa A; Sun D; Annunziato L
    Glia; 2016 Oct; 64(10):1677-97. PubMed ID: 27458821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABAB receptor trafficking and interacting proteins: targets for the development of highly specific therapeutic strategies to treat neurological disorders?
    Benke D
    Biochem Pharmacol; 2013 Dec; 86(11):1525-30. PubMed ID: 24084431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug transporters in the central nervous system.
    Stieger B; Gao B
    Clin Pharmacokinet; 2015 Mar; 54(3):225-42. PubMed ID: 25647629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of SLC xenobiotic transporters and their regulatory mechanisms PDZ proteins in drug delivery and disposition.
    Sugiura T; Kato Y; Tsuji A
    J Control Release; 2006 Nov; 116(2):238-46. PubMed ID: 16876283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomaterial applications for neurological diseases and central nervous system injury.
    Huang L; Hu J; Huang S; Wang B; Siaw-Debrah F; Nyanzu M; Zhang Y; Zhuge Q
    Prog Neurobiol; 2017 Oct; 157():29-48. PubMed ID: 28743465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane transporters in drug development.
    Keogh JP
    Adv Pharmacol; 2012; 63():1-42. PubMed ID: 22776638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane transporter proteins: a challenge for CNS drug development.
    Girardin F
    Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.